1. Home
  2. AURA vs PACB Comparison

AURA vs PACB Comparison

Compare AURA & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
    SELLHOLDBUYas of 3 days ago
  • PACB
    SELLHOLDBUYas of 3 days ago
  • Stock Information
  • Founded
  • AURA 2007
  • PACB 2000
  • Country
  • AURA United States
  • PACB United States
  • Employees
  • AURA N/A
  • PACB N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • PACB Biotechnology: Laboratory Analytical Instruments
  • Sector
  • AURA Health Care
  • PACB Industrials
  • Exchange
  • AURA Nasdaq
  • PACB Nasdaq
  • Market Cap
  • AURA 438.3M
  • PACB 452.1M
  • IPO Year
  • AURA 2021
  • PACB 2010
  • Fundamental
  • Price
  • AURA $8.20
  • PACB $1.97
  • Analyst Decision
  • AURA Strong Buy
  • PACB Buy
  • Analyst Count
  • AURA 4
  • PACB 15
  • Target Price
  • AURA $23.00
  • PACB $2.92
  • AVG Volume (30 Days)
  • AURA 217.1K
  • PACB 9.3M
  • Earning Date
  • AURA 11-12-2024
  • PACB 02-13-2025
  • Dividend Yield
  • AURA N/A
  • PACB N/A
  • EPS Growth
  • AURA N/A
  • PACB N/A
  • EPS
  • AURA N/A
  • PACB N/A
  • Revenue
  • AURA N/A
  • PACB $173,147,000.00
  • Revenue This Year
  • AURA N/A
  • PACB N/A
  • Revenue Next Year
  • AURA N/A
  • PACB $22.06
  • P/E Ratio
  • AURA N/A
  • PACB N/A
  • Revenue Growth
  • AURA N/A
  • PACB 2.14
  • 52 Week Low
  • AURA $6.63
  • PACB $1.16
  • 52 Week High
  • AURA $12.38
  • PACB $10.65
  • Technical
  • Relative Strength Index (RSI)
  • AURA 39.04
  • PACB 49.39
  • Support Level
  • AURA $8.03
  • PACB $1.81
  • Resistance Level
  • AURA $9.04
  • PACB $2.13
  • Average True Range (ATR)
  • AURA 0.46
  • PACB 0.21
  • MACD
  • AURA -0.01
  • PACB -0.01
  • Stochastic Oscillator
  • AURA 15.20
  • PACB 25.76

Stock Price Comparison Chart: AURA vs PACB

AURA
PACB
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober0510152025303540455055AURA VS PACB

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use